Sodium thiosulphate: A new way of treatment for calciphylaxis?

Dermatology

Volumn 214, Issue 4, 2007, Pages 278-282

  Meissner, M ^a   Kaufmann, R ^a   Gille, J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Calciphylaxis; Calcium; Phosphate; Sodium thiosulphate

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CINACALCET; SODIUM THIOSULFATE; VITAMIN D DERIVATIVE;

ANALGESIA; ASPIRATION PNEUMONIA; CALCINOSIS; CALCIUM BLOOD LEVEL; DIALYSIS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; HYPERPARATHYROIDISM; HYPOALBUMINEMIA; METABOLIC ACIDOSIS; NAUSEA; OBESITY; OSTEOPOROSIS; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; VOMITING;

ANTIOXIDANTS; CALCIPHYLAXIS; CHELATING AGENTS; HUMANS; KIDNEY DISEASES; THIOSULFATES;

EID: 34247528498     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100877     Document Type: Review

References (33)

1. Holleman AF, Wiberg E: Inorganic Chemistry. San Diego, Academic Press, 2001.
2. Erdlenbruch B, Pekrun A, Schiffmann H, Witt O, Lakomek M: Topical topic: accidental cisplatin overdose in a child - reversal of acute renal failure with sodium thiosulphate. Med Pediatr Oncol 2002;38:349-352.
3. Yatzidis H: Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol 1985;23:63-67.
4. Agroyannis BJ, Koutsikos DK, Tzanatos HA, Konstadinidou IK: Sodium thiosulphate in the treatment of renal tubular acidosis I with nephrocalcinosis. Scand J Urol Nephrol 1994;28:107-108.
5. Agroyannis B, Tzanatos H, Vlahakos DV, Mallas E: Does long-term administration of sodium thiosulphate inhibit progression to renal failure in nephrocalcinosis? Nephrol Dial Transplant 2001;16:2443-2444.
6. Kyriakopoulos G, Kontogianni K: Sodium thiosulphate treatment of tumoral calcinosis in patients with end-stage renal disease. Ren Fail 1990;12:213-219.
7. Papadakis JT, Patrikarea A, Digenis GE, Stamatelou K, Ntaountaki I, Athanasopoulos V, Tamvakis N: Sodium thiosulphate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism. Nephron 1996;72:308-312.
8. Angelis M, Wong LL, Myers SA, Wong LM: Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery 1997;122:1083-1089.
9. Ledbetter LS, Khoshnevis MR, Hsu S: Calciphylaxis. Cutis 2000;66:49-51.
10. Meissner M, Gille J, Kaufmann R: Calciphylaxis: no therapeutic concepts for a poorly understood syndrome? J Dtsch Dermatol Ges 2006;4:1037-1044.
11. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-366.
12. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
13. Ahmed S, O'Neill KD, Hood AF, Evan AP, Moe SM: Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 2001;37:1267-1276.
14. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX: Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003;63:1003-1011.
15. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002;61:638-647.
16. Jono S, Peinado C, Giachelli CM: Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 2000;275:20197-20203.
17. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM: Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001;89:1147-1154.
18. Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R: Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulphate. Cardiovasc Diabetol 2005;4:4.
19. Essary LR, Wick MR: Cutaneous calciphylaxis: an underrecognized clinicopathologic entity. Am J Clin Pathol 2000;113:280-287.
20. Basile C, Montanaro A, Masi M, Pati G, De Maio P, Gismondi A: Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. J Nephrol 2002;15:676-680.
21. Duffy A, Schurr M, Warner T, Chen H: Long-term outcomes in patients with calciphylaxis from hyperparathyroidism. Ann Surg Oncol 2006;13:96-102.
22. Block GA, Port FK: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 2000;35:1226-1237.
23. Basile C, Montanaro A, Masi M, Pati G, De Maio P, Gismondi A: Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. J Nephrol 2002;15:676-680.
24. Lipsker D, Chosidow O, Martinez F, Challier E, Frances C: Low-calcium dialysis in calciphylaxis. Arch Dermatol 1997;133:798-799.
25. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulphate. Am J Kidney Dis 2004;43:1104-1108.
26. Meissner M, Bauer R, Beier C, Betz C, Wol ter M, Kaufmann R, Gille J: Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis. Dermatology 2006;212:373-376.
27. Brucculeri M, Cheigh J, Bauer G, Serur D: Long-term intravenous sodium thiosulphate in the treatment of a patient with calciphylaxis. Semin Dial 2005;18:431-434.
28. Guerra G, Shah RC, Ross EA: Rapid resolution of calciphylaxis with intravenous sodium thiosulphate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. Nephrol Dial Transplant 2005;20:1260-1262.
29. Tokashiki K, Ishida A, Kouchi M, Ishihara S, Tomiyama N, Kohagura K, Iseki K, Takishita S: Successful management of critical limb ischemia with intravenous sodium thiosulphate in a chronic hemodialysis patient. Clin Nephrol 2006;66:140-143.
30. Mataic D, Bastani B: Intraperitoneal sodium thiosulphate for the treatment of calciphylaxis. Ren Fail 2006;28:361-363.
31. Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR: Sodium thiosulphate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 2006;1:1161-1166.
32. Thang OH, Jaspars EH, ter Wee PM: Necrotizing mastitis caused by calciphylaxis. Nephrol Dial Transplant 2006;21:2020-2021.
33. Mehrotra R, Kopple JD, Wolfson M: Metabolic acidosis in maintenance dialysis patients: clinical considerations. Kidney Int Suppl 2003:S13-25.